Trials / Withdrawn
WithdrawnNCT03849326
Chronic Fatigue Etiology in Intensive Care Unit Survivors: the Role of Neuromuscular Function
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Chronic fatigue is the most common and debilitating symptom in intensive care unit (ICU) survivors. Indeed, it has been widely reported that patients who stayed in ICU for prolonged periods report a feeling of tiredness for months to years after ICU discharge. This chronic fatigue affects their quality of life by decreasing their capacity to perform simple tasks of daily life. The aim of the present project is to determine whether deteriorated neuromuscular function (i.e. increased fatigability) is involved in this feeling of chronic fatigue. Because the causes of this feeling are multi-dimensional, a large battery of tests will allow us to better understand the origin of chronic fatigue. A better knowledge of chronic fatigue etiology will allow to optimize rehabilitation treatments to decrease the apparition/persistence of chronic fatigue and in fine improve life quality.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Questionnaires | Quality of life Depression Physical pain Social provisions Quality of sleep |
| BIOLOGICAL | blood test | complete blood count and cytokine concentration |
| OTHER | Maximal effort test | The maximal effort test with VO2max recordings will be assessed during the first visit to the laboratory. |
| DEVICE | actigraphy | assessment of sleep quality |
| DEVICE | Neuromuscular evaluation | * The maximum isometric force produced by the knee extensors will be measured on the ergometer * the intensity of muscular electrical activity recorded by surface electromyography * Peripheral nerve stimulation * Transcranial magnetic stimulation * Magnetic resonance imaging (optional) |
Timeline
- Start date
- 2023-12-01
- Primary completion
- 2025-03-01
- Completion
- 2025-04-01
- First posted
- 2019-02-21
- Last updated
- 2023-04-26
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03849326. Inclusion in this directory is not an endorsement.